LRMR
Larimar Therapeutics Inc
3.10$
-7.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -11.69 | -26.71 | -22.85 | -19.15 | -19.17 | -7.29 | -3.55 | -2.45 | -1.07 | -0.76 | -1.16 | -1.55 | |
| 0.01 | 0.03 | 0.09 | 0.08 | 0.10 | 0.03 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 | |
| 0.64 | 3.85 | – | – | 0.06 | 0.04 | 0.18 | 0.32 | 0.26 | 0.17 | 0.14 | 0.10 | |
| – | – | – | – | 0.06 | 0.04 | 0.18 | 0.32 | 0.26 | – | – | – | |
| 0.34 | 3.02 | -2.42 | -0.04 | 0.22 | 0.07 | -0.17 | 0.16 | 0.06 | -0.06 | 0.10 | 0.65 | |
| 0.02 | 0.27 | 0.29 | 0.02 | 0.04 | 0.03 | 0.01 | 0.02 | 0.00 | 0.00 | 0.01 | 0.00 | |
| -23.72 | -41.31 | 22.62 | 15.59 | -2.56 | -0.03 | 1.44 | 1.41 | -3.53 | 0.76 | -1.39 | 1.38 | |
| – | 58.76 | 0.10 | 0.09 | 25.03 | 0.06 | 6.36 | – | 2.92 | – | – | – | |
| 44.76 | 57.93 | -1.19 | 7.24 | 24.91 | 6.23 | 7.88 | 1.16 | 2.92 | 0.00 | 2.64 | 0.89 | |
| 9.35 | -10.09 | -1.43 | 3.69 | 3.18 | -15.51 | 5.76 | 0.11 | -1.68 | 0.00 | 0.09 | 0.72 | |
| -11.71 | -26.98 | -23.14 | -19.18 | -19.21 | -7.31 | -3.56 | -2.47 | -1.07 | -0.77 | -1.16 | -1.55 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.